PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 109 filers reported holding PMV PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.34 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $969,000 | +33.5% | 46,528 | +48.1% | 0.00% | – |
| Q4 2021 | $726,000 | -13.5% | 31,418 | +11.6% | 0.00% | – |
| Q3 2021 | $839,000 | +8.4% | 28,145 | +24.2% | 0.00% | – |
| Q2 2021 | $774,000 | +12.2% | 22,663 | +8.1% | 0.00% | – |
| Q1 2021 | $690,000 | -38.1% | 20,969 | +15.8% | 0.00% | -100.0% |
| Q4 2020 | $1,114,000 | +191.6% | 18,114 | +68.3% | 0.00% | – |
| Q3 2020 | $382,000 | – | 10,763 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $23,012,000 | 42.78% |
| Euclidean Capital LLC | 2,336,909 | $33,301,000 | 28.32% |
| OUP Management Co., LLC | 989,232 | $14,097,000 | 19.40% |
| Nextech Invest Ltd. | 1,385,807 | $19,748,000 | 6.66% |
| Boxer Capital, LLC | 3,498,636 | $49,856,000 | 3.16% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $7,842,000 | 1.84% |
| Orbimed Advisors | 6,563,077 | $93,524,000 | 1.70% |
| RTW INVESTMENTS, LP | 4,395,677 | $62,638,000 | 1.62% |
| ACUTA CAPITAL PARTNERS, LLC | 152,500 | $2,173,000 | 1.21% |
| Avoro Capital Advisors LLC | 3,100,000 | $44,175,000 | 0.87% |